Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2025 Mar;17(3):e70065.
doi: 10.1111/1753-0407.70065.

Association of Glycaemia Risk Index With Indices of Atherosclerosis: A Cross-Sectional Study

Affiliations
Multicenter Study

Association of Glycaemia Risk Index With Indices of Atherosclerosis: A Cross-Sectional Study

Keiichi Torimoto et al. J Diabetes. 2025 Mar.

Erratum in

Abstract

Aims: This study determined the association of the glycaemia risk index (GRI), a novel comprehensive metric derived from continuous glucose monitoring (CGM), and atherosclerosis in patients with type 2 diabetes (T2DM).

Methods: We evaluated the relationship between GRI and intima-media thickness (IMT), gray-scale median (GSM), tissue characteristics of the carotid artery wall, and brachial-ankle pulse wave velocity (baPWV), using baseline data from a multicenter prospective cohort study of 1000 Japanese patients with T2DM free of cardiovascular disease (CVD).

Results: The study subjects were 999 patients (age: 64.6 ± 9.6 years, mean ± SD, 60.9% males, body mass index: 24.6 ± 3.9 kg/m2, HbA1c 7.1% ± 0.8%, TIR 78.9% ± 18.6%) with T2DM (duration of 12.9 ± 8.5 years). A higher GRI was associated with a longer duration of diabetes, a higher HbA1c level, a mean glucose level, and baPWV, and lower mean GSM. No association was noted between GRI and mean IMT. GRI was significantly associated with mean GSM (regression coefficient, β = -0.1277; 95% confidence interval: CI: -0.2165 to -0.0390, p = 0.005) and baPWV (regression coefficient, β = -3.1568; 95% CI: 1.5058 to 4.8079, p < 0.001) after adjustment for various cardiovascular risk factors.

Conclusions: GRI is a potentially useful predictor of atherosclerosis in patients with T2DM. Our findings suggest that GRI, a marker of the risk of hypoglycaemia and hyperglycaemia, may serve as a clinically useful tool for the assessment of the risk of CVD in patients with T2DM, independent of the classical cardiovascular risk factors.

Keywords: atherosclerosis; continuous glucose monitoring (CGM); flash glucose monitoring (FGM); glycaemia risk index (GRI); time in range (TIR); type 2 diabetes (T2DM).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

FIGURE 1
FIGURE 1
Relationship between GRI and indices of arteriosclerosis. (a) GRI in tertiles (Q1–Q3) of GSM. Q1: < 38.5 (n = 203), Q2: ≥ 38.5 to < 52.0 (n = 199), Q3: ≥ 52.0 (n = 197). (b) The GRI in tertiles (Q1–Q3) of thickened lesion‐GSM. Q1: < 33.0 (n = 186), Q2: ≥ 33.0 to < 50.0 (n = 194), Q3: ≥ 50.0 (n = 186). (c) The GRI in tertiles (Q1–Q3) of plaque‐GSM. Q1: < 46.0 (n = 163), Q2: ≥ 46.0 to < 67.0 (n = 158), Q3: ≥ 67.0 (n = 169). (d) The GRI in groups with [IMT‐thickness: IMT ≥ 1.0 mm (n = 28)], and without IMT‐thickening [IMT‐thickness: IMT < 1.0 mm (n = 572)]. (e) GRI of the high [baPWV ≥ 1800 cm/s (n = 149)] and low [baPWV < 1800 cm/s (n = 296)] arterial stiffness groups. baPWV, brachial‐ankle pulse wave velocity; GRI, glycaemia risk index; GSM, grayscale median; IMT, intima‐media thickness.

References

    1. Sun H., Saeedi P., Karuranga S., et al., “IDF Diabetes Atlas: Global, Regional and Country‐Level Diabetes Prevalence Estimates for 2021 and Projections for 2045,” Diabetes Research and Clinical Practice 183 (2022): 109119, 10.1016/j.diabres.2021.109119. - DOI - PMC - PubMed
    1. Rask‐Madsen C. and King G. L., “Mechanisms of Disease: Endothelial Dysfunction in Insulin Resistance and Diabetes,” Nature Clinical Practice. Endocrinology & Metabolism 3, no. 1 (2007): 46–56, 10.1038/ncpendmet0366. - DOI - PubMed
    1. El‐Barghouty N. M., Levine T., Ladva S., et al., “Histological Verification of Computerised Carotid Plaque Characterisation,” European Journal of Vascular and Endovascular Surgery 11, no. 4 (1996): 414–416, 10.1016/s1078-5884(96)80172-9. - DOI - PubMed
    1. Taya N., Katakami N., Mita T., et al., “Associations of Continuous Glucose Monitoring‐Assessed Glucose Variability With Intima‐Media Thickness and Ultrasonic Tissue Characteristics of the Carotid Arteries: A Cross‐Sectional Analysis in Patients With Type 2 Diabetes,” Cardiovascular Diabetology 20, no. 1 (2021): 95, 10.1186/s12933-021-01288-5. - DOI - PMC - PubMed
    1. Klonoff D. C., Wang J., Rodbard D., et al., “A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings,” Journal of Diabetes Science and Technology 17, no. 5 (2023): 1226–1242, 10.1177/19322968221085273. - DOI - PMC - PubMed

Publication types

MeSH terms